Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy

Peisen, Felix; Gerken, Annika; Dahm, Isabel; Nikolaou, Konstantin; Eigentler, Thomas; Amaral, Teresa; Moltz, Jan H.; Othman, Ahmed E.; Gatidis, Sergios; Dondi, Francesco

dc.contributor.author	Dahm, Isabel
dc.contributor.author	Nikolaou, Konstantin
dc.contributor.author	Eigentler, Thomas
dc.contributor.author	Amaral, Teresa
dc.contributor.author	Gatidis, Sergios
dc.contributor.author	Peisen, Felix Ludwig
dc.contributor.author	Othman, Ahmed
dc.date.accessioned	2024-07-29T08:38:29Z
dc.date.available	2024-07-29T08:38:29Z
dc.date.issued	2024
dc.identifier.issn	1932-6203
dc.identifier.uri	http://hdl.handle.net/10900/155852
dc.language.iso	en	de_DE
dc.publisher	San Francisco : Public Library Science	de_DE
dc.relation.uri	http://dx.doi.org/10.1371/journal.pone.0296253	de_DE
dc.subject.ddc	500	de_DE
dc.title	Pre-treatment 18F-FDG-PET/CT parameters as biomarkers for progression free survival, best overall response and overall survival in metastatic melanoma patients undergoing first-line immunotherapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240422000000_01000
utue.personen.roh	Peisen, Felix
utue.personen.roh	Gerken, Annika
utue.personen.roh	Dahm, Isabel
utue.personen.roh	Nikolaou, Konstantin
utue.personen.roh	Eigentler, Thomas
utue.personen.roh	Amaral, Teresa
utue.personen.roh	Moltz, Jan H.
utue.personen.roh	Othman, Ahmed E.
utue.personen.roh	Gatidis, Sergios
utue.personen.roh	Dondi, Francesco
dcterms.isPartOf.ZSTitelID	Plos One	de_DE
dcterms.isPartOf.ZS-Issue	Article e0296253	de_DE
dcterms.isPartOf.ZS-Volume	19 (1)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE